Literature DB >> 9842910

MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositol-anchored proteins and Src-like tyrosine kinases.

J Millán1, M A Alonso.   

Abstract

A large fraction of glycosylphosphatidylinositol (GPI)-anchored proteins and Src-like kinases are confined to glycolipid-enriched membrane (GEM) microdomains. The particular membrane topology of GPI-anchored proteins has led to the postulation of the existence of integral membrane proteins linking extracellular stimuli with cytosolic machinery for endocytosis and signaling. The human MAL cDNA was identified during a search for novel genes differentially expressed during T cell development, and encodes a multispanning membrane protein displaying lipid-like properties. To address the biochemical characterization of endogenous MAL and to analyze its possible association with other proteins, we have generated a monoclonal antibody (mAb) specific to the MAL molecule. Using this mAb, we have identified MAL in GEM microdomains of both the HPB-ALL T cell line and human peripheral blood lymphocytes. Co-immunoprecipitation experiments with antibodies to the MAL molecule or to the GPI-anchored CD59 antigen indicated specific association of MAL with GPI-anchored proteins and Src-like tyrosine kinases. In addition, both MAL and the Src-like kinase Lck were identified in GEM obtained from an endosomal-enriched membrane fraction. These features of MAL closely match some of the properties expected for the hypothetical integral membrane linker proteins acting in specialized GEM-mediated functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842910     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3675::AID-IMMU3675>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  MAL, an integral element of the apical sorting machinery, is an itinerant protein that cycles between the trans-Golgi network and the plasma membrane.

Authors:  R Puertollano; M A Alonso
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

Review 2.  Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform.

Authors:  D C Hoessli; S Ilangumaran; A Soltermann; P J Robinson; B Borisch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

3.  An intact dilysine-like motif in the carboxyl terminus of MAL is required for normal apical transport of the influenza virus hemagglutinin cargo protein in epithelial Madin-Darby canine kidney cells.

Authors:  R Puertollano; J A Martínez-Menárguez; A Batista; J Ballesta; M A Alonso
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

Review 4.  Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.

Authors:  Pier Luigi Zinzani; Pier Paolo Piccaluga
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

5.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 6.  Regulating ENaC's gate.

Authors:  Thomas R Kleyman; Douglas C Eaton
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

7.  VIP17/MAL expression modulates epithelial cyst formation and ciliogenesis.

Authors:  Vinita Takiar; Kavita Mistry; Monica Carmosino; Nicole Schaeren-Wiemers; Michael J Caplan
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-15       Impact factor: 4.249

8.  Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.

Authors:  Angela E Fritzinger; Denise M Toney; Rebecca C MacLean; Francine Marciano-Cabral
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

9.  Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis.

Authors:  Samir Kumar Pal; Sunaki Noguchi; Gou Yamamoto; Atsushi Yamada; Tomohide Isobe; Shigeo Hayashi; Jun-Ichi Tanaka; Yoichi Tanaka; Ryutaro Kamijo; Gen-Yuki Yamane; Tetsuhiko Tachikawa
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

10.  Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.

Authors:  Hisani N Horne; Paula S Lee; Susan K Murphy; Miguel A Alonso; John A Olson; Jeffrey R Marks
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.